SCHEMBL10237969

SCHEMBL10237969

Cc1nc(-c2ccc(Cl)cc2)sc1C1C(=O)[C@@H]2CC[C@@H](C2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ MAPT P10636 7/20 0.42
▸ ALDH1A1 P00352 5/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ XDH P47989 1/20 0.37
▸ CHRM4 P08173 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ PRCP P42785 1/20 0.36
▸ TRPM8 Q7Z2W7 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10237998 0.86 SLC6A3 (0.39) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL10237934 0.82 RAB9A (0.40) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL13058537 0.81 KDM4E (0.43) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL10237997 0.81 GRM2 (0.34) SLC6A3CYP3A4
SCHEMBL10238015 0.79 ALDH1A1 (0.40) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL10238001 0.77 ALDH1A1 (0.39) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL16215992 0.77 HRH3 (0.41) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL608047 0.77 HRH3 (0.41) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL10237937 0.77 HRH3 (0.41) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL13041525 0.74 KDM4E (0.46) SMN1; SMN2RAB9ANPC1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176222-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2014-11-05 — — EP disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040826-A1 NOVEL HERBICIDES DDT, HDHD5, DDC SMN1; SMN2 4358/4885RAB9A 3059/4885NPC1 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback